Public Sector Pension Investment Board Arrowhead Pharmaceuticals, Inc. Transaction History

Public Sector Pension Investment Board

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$58.09 - $82.51 $203,489 - $289,032	-3,503 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$58.38 - $84.96 $204,505 - $297,614	3,503 New	3,503 $219,000
Q4 2019 Feb 14, 2020	SELL	$28.14 - $73.01 $6.82 Million - $17.7 Million	-242,224 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$26.26 - $34.86 $872,462 - $1.16 Million	33,224 Added 15.9%	242,224 $6.83 Million
Q2 2019 Aug 14, 2019	BUY	$17.43 - $28.82 $3.64 Million - $6.02 Million	209,000 New	209,000 $5.54 Million

304

95.8M

523K

493K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.64B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Public Sector Pension Investment Board, based on Form 13F filings with the SEC.

Stay updated on Public Sector Pension Investment Board with notifications on news.